Auris Medical Holding Ltd (EARS)

HEALTH CARE: HEALTH CARE SUPPLIES
SIC: PHARMACEUTICAL PREPARATIONS

BAHNHOFSTRASSE 21 6300 ZUG, SWITZERLAND

Auris Medical Holding AG develops and markets therapies for the treatment of hearing loss and tinnitus. The Company specializes in the development of cochlear therapies for the treatment of acute inner ear tinnitus and acute sensorineural hearing loss from acute acoustic trauma, sudden deafness, or in middle and inner ear surgery. Auris Medical markets its products internationally.

Data based on most recent fiscal year report
Market Cap93.59 Million Shares Outstanding61.17 Million Avg Volume1.11 Million
1-Yr BETA vs S&P TR0 Current Ratio1.52 Quick Ratio1.52
View SEC Filings from EARS instead.
Q2 2019 All Institutions Hedge Funds 1
To trade EARS now:
Filers who had this stock in their top 10: 0 0 (0.0%)
13F Filers holding this stock: 6 1 (0.1%)
Aggregate 13F shares on 06/30/2019: 191.738 Thousand 123.59 Thousand
Aggregate 13F shares on 03/31/2019: 1.523 Thousand 0
Percent change: 12489.49%
Funds creating new positions: 2 1
Funds Adding to an existing position: 3
Funds closing out their position: 8
Funds reducing their position:
1 hedge funds as identified by whalewisdom.com through public filings.

Funds Holding EARS (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

Insider Transactions Last 60 Days

Reporting Owners Transaction Date Transaction Code Shares Share Price Acquired or Disposed Shares Owned Following Transaction Combined shares owned after filing Direct/Indirect Ownership 10b-5
No current insider transactions
Click here to report any possible errors with this stock listing.

Elevate your investments